http://www.akceatx.com
Akcea Therapeutics, Inc. Company Intro
Our Commitment At Akcea, we’re on a mission to transform the treatment of unaddressed or under-addressed serious and rare diseases with leading-edge, RNA-targeted medicines. Whether you’re a patient living with a serious condition, or a physician whose patient desperately needs a therapy, we know you’re counting on us, and it fuels our unwavering commitment to … Continue reading "Home"
Industry
Healthcare
Akcea Therapeutics, Inc. Headquaters
22 Boston Wharf Road
Boston,02210
United States
Akcea Therapeutics, Inc. Share price
19 Jan 2021 01:04 GMT
$18.15
-0.02 (-0.11 %)
Akcea Therapeutics, Inc. Market cap
$1.846 B
WMC RANKING
2021
Akcea Therapeutics, Inc. # 23
BiotechnologyLatest Akcea Therapeutics, Inc. News
15 Jan 2021
CNS Specific Antisense Oligonucleotides Market Share 2020 With Top Manufacturers: ABB, Cisco, Rockwell Automation, Schneider Electric, Siemens
Akcea Therapeutics, Inc. Ionis Pharmaceuticals Inc. Biogen Inc. Sarepta Therapeutics Wave Life Sciences Ltd. Dynacure ProQR Therapeutics N.V.. Stroke ...
15 Jan 2021
CNS Specific Antisense Oligonucleotides Market Share 2020 With Top Manufacturers: ABB, Cisco, Rockwell Automation, Schneider Electric, Siemens
Akcea Therapeutics, Inc. Ionis Pharmaceuticals Inc. Biogen Inc. Sarepta Therapeutics Wave Life Sciences Ltd. Dynacure ProQR Therapeutics N.V.
15 Jan 2021
CNS Specific Antisense Oligonucleotides Market Share 2020 With Top Manufacturers: ABB, Cisco, Rockwell Automation, Schneider Electric, Siemens
Akcea Therapeutics, Inc. Ionis Pharmaceuticals Inc. Biogen Inc. Sarepta Therapeutics Wave Life Sciences Ltd. Dynacure ProQR Therapeutics N.V.. Stroke ...
WMC Market Score
WMC Market to Revenue Score
Akcea Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akcea Therapeutics, Inc. | USD | $336,555 | $365,071 | $-41,519 | $18,460B | 23 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $274,470B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akcea Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Post vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Akcea Therapeutics, Inc. | 3.64 | 2.18 | 12.16 | 0 | 0 | 0 | 7.36 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.03 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.18 | 100 | 60 | 0 | 0 | 90.52 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.94 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
